C.R. Bard (BCR) 222.63 $BCR
Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:59PM CDT
Cardinal Health Inc. (CAH) reported fourth-quarter fiscal 2016 adjusted earnings of $1.14 per share, which beat the Zacks Consensus Estimate by a penny.
BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69), CAH: 84.92 (+2.51), MMSI: 23.26 (-0.34)
CONMED (CNMD) Earnings & Sales Beat in Q2, '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:45AM CDT
CONMED Corporation (CNMD) reported second-quarter 2016 adjusted earnings of 47 cents per share, surpassing the Zacks Consensus Estimate.
ABC: 89.43 (+3.89), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69), CNMD: 39.73 (-0.44)
C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:19PM CDT
C.R. Bard Inc. (BCR) reported adjusted earnings of $2.56 in the second quarter of 2016, exceeding the Zacks Consensus Estimate by a dime.
HYH: 33.84 (-0.23), BSX: 24.17 (-0.26), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69)
SmarTrend Watching for Potential Rebound in Shares of CR Bard After 4.07% Loss
Comtex SmarTrend(R) - Wed Jul 27, 2:05PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $221.01 to a high of $229.92. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $228.34 on volume of 467,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
After Yesterday's Decline of 4.07%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 27, 2:03PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $221.01 to a high of $229.92. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $228.34 on volume of 467,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 12:16PM CDT
LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.
SQNM: 2.36 (unch), BCR: 222.63 (-2.52), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
Will LabCorp (LH) Beat Earnings Estimates in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:27PM CDT
We expect Laboratory Corp. of America Holdings (LH), or LabCorp to beat expectations when it reports second-quarter 2016 results before the opening bell on Jul 27.
MCK: 193.53 (+1.44), BCR: 222.63 (-2.52), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
SmarTrend Watching for Potential Rebound in Shares of CR Bard After 1.15% Loss
Comtex SmarTrend(R) - Fri Jul 15, 1:38PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $232.09 to a high of $236.05. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $233.50 on volume of 174,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
CR Bard Has Returned 27.7% Since SmarTrend Recommendation (BCR)
Comtex SmarTrend(R) - Wed Jul 13, 12:53AM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 6 months, CR Bard has returned 27.67% as of today's recent price of $235.55.
BCR: 222.63 (-2.52)
The Cooper Companies (COO) Scales a New 52-Week High
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:09AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $182.21 on Jul 8, eventually closing a tad bit lower at $181.83.
HYH: 33.84 (-0.23), BDX: 176.43 (-0.35), BCR: 222.63 (-2.52), COO: 181.97 (-0.64)
VWR Corp Poised on Balanced Growth, Strong Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:18AM CDT
On Jul 7, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
BCR: 222.63 (-2.52), VWR: 30.76 (-0.55), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 222.63 (-2.52), LH: 139.38 (-0.25), HSIC: 179.95 (-0.19), COO: 181.97 (-0.64)
23.8% Return Seen to Date on SmarTrend CR Bard Call (BCR)
Comtex SmarTrend(R) - Mon Jun 20, 1:40PM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 5 months, CR Bard has returned 23.85% as of today's recent price of $228.50.
BCR: 222.63 (-2.52)
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY).
HYH: 33.84 (-0.23), BCR: 222.63 (-2.52), CNMD: 39.73 (-0.44), XRAY: 64.63 (+0.40)
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:07AM CDT
Becton, Dickinson and Company (BDX) recently announced a partnership with Central Admixture Pharmacy Services (CAPS).
HYH: 33.84 (-0.23), BDX: 176.43 (-0.35), BCR: 222.63 (-2.52), MDT: 87.64 (-0.42)
CR Bard Up 21.7% Since SmarTrend Uptrend Call (BCR)
Comtex SmarTrend(R) - Fri Jun 10, 1:50PM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 5 months, CR Bard has returned 21.65% as of today's recent price of $224.45.
BCR: 222.63 (-2.52)
Bard Announces $500 Million Share Repurchase Authorization
BusinessWire - Wed Jun 08, 3:15PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today authorized the repurchase of up to $500 million of the company's common stock. This is in addition to approximately $205 million remaining under the prior authorization announced in June 2015. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions.
BCR: 222.63 (-2.52)
Bard Increases Quarterly Dividend
BusinessWire - Wed Jun 08, 3:15PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today increased the quarterly dividend on Bard's common stock by 8 percent, to 26 cents per share. The dividend is payable on July 29, 2016 to shareholders of record at the close of business on July 18, 2016. This will be the 45th consecutive calendar year in which Bard has increased its annual dividend payout to shareholders.
BCR: 222.63 (-2.52)
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 33.84 (-0.23), BCR: 222.63 (-2.52), CNMD: 39.73 (-0.44), PDCO: 48.89 (-0.30)
Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:59PM CDT
Cardinal Health Inc. (CAH) reported fourth-quarter fiscal 2016 adjusted earnings of $1.14 per share, which beat the Zacks Consensus Estimate by a penny.
BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69), CAH: 84.92 (+2.51), MMSI: 23.26 (-0.34)
CONMED (CNMD) Earnings & Sales Beat in Q2, '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:45AM CDT
CONMED Corporation (CNMD) reported second-quarter 2016 adjusted earnings of 47 cents per share, surpassing the Zacks Consensus Estimate.
ABC: 89.43 (+3.89), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69), CNMD: 39.73 (-0.44)
C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:19PM CDT
C.R. Bard Inc. (BCR) reported adjusted earnings of $2.56 in the second quarter of 2016, exceeding the Zacks Consensus Estimate by a dime.
HYH: 33.84 (-0.23), BSX: 24.17 (-0.26), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69)
SmarTrend Watching for Potential Rebound in Shares of CR Bard After 4.07% Loss
Comtex SmarTrend(R) - Wed Jul 27, 2:05PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $221.01 to a high of $229.92. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $228.34 on volume of 467,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
After Yesterday's Decline of 4.07%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 27, 2:03PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $221.01 to a high of $229.92. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $228.34 on volume of 467,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 12:16PM CDT
LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.
SQNM: 2.36 (unch), BCR: 222.63 (-2.52), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
Will LabCorp (LH) Beat Earnings Estimates in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:27PM CDT
We expect Laboratory Corp. of America Holdings (LH), or LabCorp to beat expectations when it reports second-quarter 2016 results before the opening bell on Jul 27.
MCK: 193.53 (+1.44), BCR: 222.63 (-2.52), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
SmarTrend Watching for Potential Rebound in Shares of CR Bard After 1.15% Loss
Comtex SmarTrend(R) - Fri Jul 15, 1:38PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $232.09 to a high of $236.05. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $233.50 on volume of 174,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 222.63 (-2.52)
CR Bard Has Returned 27.7% Since SmarTrend Recommendation (BCR)
Comtex SmarTrend(R) - Wed Jul 13, 12:53AM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 6 months, CR Bard has returned 27.67% as of today's recent price of $235.55.
BCR: 222.63 (-2.52)
The Cooper Companies (COO) Scales a New 52-Week High
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:09AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $182.21 on Jul 8, eventually closing a tad bit lower at $181.83.
HYH: 33.84 (-0.23), BDX: 176.43 (-0.35), BCR: 222.63 (-2.52), COO: 181.97 (-0.64)
VWR Corp Poised on Balanced Growth, Strong Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:18AM CDT
On Jul 7, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
BCR: 222.63 (-2.52), VWR: 30.76 (-0.55), LH: 139.38 (-0.25), COO: 181.97 (-0.64)
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 222.63 (-2.52), LH: 139.38 (-0.25), HSIC: 179.95 (-0.19), COO: 181.97 (-0.64)
23.8% Return Seen to Date on SmarTrend CR Bard Call (BCR)
Comtex SmarTrend(R) - Mon Jun 20, 1:40PM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 5 months, CR Bard has returned 23.85% as of today's recent price of $228.50.
BCR: 222.63 (-2.52)
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY).
HYH: 33.84 (-0.23), BCR: 222.63 (-2.52), CNMD: 39.73 (-0.44), XRAY: 64.63 (+0.40)
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:07AM CDT
Becton, Dickinson and Company (BDX) recently announced a partnership with Central Admixture Pharmacy Services (CAPS).
HYH: 33.84 (-0.23), BDX: 176.43 (-0.35), BCR: 222.63 (-2.52), MDT: 87.64 (-0.42)
CR Bard Up 21.7% Since SmarTrend Uptrend Call (BCR)
Comtex SmarTrend(R) - Fri Jun 10, 1:50PM CDT
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on January 25th, 2016 at $184.50. In approximately 5 months, CR Bard has returned 21.65% as of today's recent price of $224.45.
BCR: 222.63 (-2.52)
Bard Announces $500 Million Share Repurchase Authorization
BusinessWire - Wed Jun 08, 3:15PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today authorized the repurchase of up to $500 million of the company's common stock. This is in addition to approximately $205 million remaining under the prior authorization announced in June 2015. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions.
BCR: 222.63 (-2.52)
Bard Increases Quarterly Dividend
BusinessWire - Wed Jun 08, 3:15PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today increased the quarterly dividend on Bard's common stock by 8 percent, to 26 cents per share. The dividend is payable on July 29, 2016 to shareholders of record at the close of business on July 18, 2016. This will be the 45th consecutive calendar year in which Bard has increased its annual dividend payout to shareholders.
BCR: 222.63 (-2.52)
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 33.84 (-0.23), BCR: 222.63 (-2.52), CNMD: 39.73 (-0.44), PDCO: 48.89 (-0.30)
